vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.

ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). ZIPRECRUITER, INC. runs the higher net margin — -0.7% vs -38.1%, a 37.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -4.4%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PRCT vs ZIP — Head-to-Head

Bigger by revenue
ZIP
ZIP
1.3× larger
ZIP
$111.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+19.6% gap
PRCT
20.2%
0.6%
ZIP
Higher net margin
ZIP
ZIP
37.3% more per $
ZIP
-0.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-4.4%
ZIP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
ZIP
ZIP
Revenue
$83.1M
$111.7M
Net Profit
$-31.6M
$-835.0K
Gross Margin
64.9%
89.1%
Operating Margin
-4.1%
3.6%
Net Margin
-38.1%
-0.7%
Revenue YoY
20.2%
0.6%
Net Profit YoY
-27.9%
92.3%
EPS (diluted)
$-0.56
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
ZIP
ZIP
Q1 26
$83.1M
Q4 25
$76.4M
$111.7M
Q3 25
$83.3M
$115.0M
Q2 25
$79.2M
$112.2M
Q1 25
$69.2M
$110.1M
Q4 24
$68.2M
$111.0M
Q3 24
$58.4M
$117.1M
Q2 24
$53.4M
$123.7M
Net Profit
PRCT
PRCT
ZIP
ZIP
Q1 26
$-31.6M
Q4 25
$-29.8M
$-835.0K
Q3 25
$-21.4M
$-9.8M
Q2 25
$-19.6M
$-9.5M
Q1 25
$-24.7M
$-12.8M
Q4 24
$-18.9M
$-10.8M
Q3 24
$-21.0M
$-2.6M
Q2 24
$-25.6M
$7.0M
Gross Margin
PRCT
PRCT
ZIP
ZIP
Q1 26
64.9%
Q4 25
60.6%
89.1%
Q3 25
64.8%
89.1%
Q2 25
65.4%
89.3%
Q1 25
63.9%
89.4%
Q4 24
64.0%
89.6%
Q3 24
63.2%
89.4%
Q2 24
59.0%
89.5%
Operating Margin
PRCT
PRCT
ZIP
ZIP
Q1 26
-4.1%
Q4 25
-40.6%
3.6%
Q3 25
-27.8%
-4.4%
Q2 25
-28.0%
-5.9%
Q1 25
-39.7%
-10.6%
Q4 24
-28.9%
-3.6%
Q3 24
-38.4%
-2.8%
Q2 24
-50.3%
7.6%
Net Margin
PRCT
PRCT
ZIP
ZIP
Q1 26
-38.1%
Q4 25
-39.1%
-0.7%
Q3 25
-25.7%
-8.5%
Q2 25
-24.7%
-8.5%
Q1 25
-35.8%
-11.7%
Q4 24
-27.6%
-9.7%
Q3 24
-35.9%
-2.2%
Q2 24
-48.0%
5.7%
EPS (diluted)
PRCT
PRCT
ZIP
ZIP
Q1 26
$-0.56
Q4 25
$-0.54
$-0.03
Q3 25
$-0.38
$-0.11
Q2 25
$-0.35
$-0.10
Q1 25
$-0.45
$-0.13
Q4 24
$-0.34
$-0.10
Q3 24
$-0.40
$-0.03
Q2 24
$-0.50
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
ZIP
ZIP
Cash + ST InvestmentsLiquidity on hand
$245.6M
$188.0M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$-77.2M
Total Assets
$487.1M
$569.7M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
ZIP
ZIP
Q1 26
$245.6M
Q4 25
$286.5M
$188.0M
Q3 25
$294.3M
$211.8M
Q2 25
$302.7M
$203.5M
Q1 25
$316.2M
$221.1M
Q4 24
$333.7M
$218.4M
Q3 24
$196.8M
$225.6M
Q2 24
$214.1M
$271.7M
Total Debt
PRCT
PRCT
ZIP
ZIP
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
ZIP
ZIP
Q1 26
$347.7M
Q4 25
$365.9M
$-77.2M
Q3 25
$380.3M
$-76.1M
Q2 25
$385.8M
$-65.9M
Q1 25
$389.2M
$-11.3M
Q4 24
$402.2M
$13.4M
Q3 24
$241.2M
$13.6M
Q2 24
$251.8M
$24.4M
Total Assets
PRCT
PRCT
ZIP
ZIP
Q1 26
$487.1M
Q4 25
$508.1M
$569.7M
Q3 25
$511.5M
$573.6M
Q2 25
$513.1M
$592.4M
Q1 25
$519.4M
$629.4M
Q4 24
$534.0M
$664.1M
Q3 24
$374.1M
$652.0M
Q2 24
$374.4M
$665.3M
Debt / Equity
PRCT
PRCT
ZIP
ZIP
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
ZIP
ZIP
Operating Cash FlowLast quarter
$7.7M
Free Cash FlowOCF − Capex
$7.6M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
ZIP
ZIP
Q1 26
Q4 25
$-10.3M
$7.7M
Q3 25
$-6.6M
$2.6M
Q2 25
$-15.0M
$10.5M
Q1 25
$-17.0M
$-9.9M
Q4 24
$-32.4M
$12.5M
Q3 24
$-18.8M
$9.3M
Q2 24
$-15.7M
$21.9M
Free Cash Flow
PRCT
PRCT
ZIP
ZIP
Q1 26
Q4 25
$-12.2M
$7.6M
Q3 25
$-9.5M
$2.2M
Q2 25
$-17.8M
$10.2M
Q1 25
$-18.8M
$-10.2M
Q4 24
$-33.6M
$12.0M
Q3 24
$-19.0M
$9.2M
Q2 24
$-16.8M
$21.7M
FCF Margin
PRCT
PRCT
ZIP
ZIP
Q1 26
Q4 25
-15.9%
6.8%
Q3 25
-11.4%
1.9%
Q2 25
-22.5%
9.1%
Q1 25
-27.2%
-9.3%
Q4 24
-49.2%
10.8%
Q3 24
-32.6%
7.8%
Q2 24
-31.4%
17.6%
Capex Intensity
PRCT
PRCT
ZIP
ZIP
Q1 26
Q4 25
2.4%
0.1%
Q3 25
3.4%
0.3%
Q2 25
3.5%
0.3%
Q1 25
2.7%
0.3%
Q4 24
1.7%
0.4%
Q3 24
0.4%
0.2%
Q2 24
2.0%
0.1%
Cash Conversion
PRCT
PRCT
ZIP
ZIP
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
3.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

ZIP
ZIP

License$84.3M75%
Services$27.4M25%

Related Comparisons